Preeclampsia Foundation-funded Genetic Research Study Finds Two Distinct Molecular “Faces” of Preeclampsia

This post was originally published on this siteMELBOURNE, Fla., Aug. 29, 2023 /PRNewswire/ — Amit Zeisel, PhD and Ido Solt, MD and their research team at the Technion – Israel Institute of Technology and Rambam Hospital, together with Prof. Simcha Yagel, MD of Hadassa Hospital, have published new research that provides systematic…

Continue Reading

Covariate Adjustment in Randomized Clinical Trials Based on Latest FDA Guidance: Application to Composite Covariates, Upcoming Webinar Hosted by Xtalks

This post was originally published on this siteIn this free webinar, gain a comprehensive review of the new FDA guidance on covariate adjustment in clinical trials. Attendees will explore the advantages of covariate adjustment with a prognostic composite covariate — maximizing trial efficiency in compliance with the FDA guidance. The…

Continue Reading

MiQ Publishes First Half 2023 Corporate Update: Largest Methane Emissions Certifier Expands Ecosystem, Now Certifying 20% of U.S. Natural Gas Production

This post was originally published on this siteMiQ continues to expand its geographical footprint, independently certifying 18 facilities from 11 natural gas producers during the first half of 2023 At CERAWeek, bp announced the expansion of natural gas certification to 100% of its onshore upstream operations, with Chesapeake achieving…

Continue Reading

ICU Medical Receives FDA Clearance for Plum Duo™ Infusion Pump and LifeShield™ Infusion Safety Software

This post was originally published on this siteThe clinician-driven design of the precision system is the foundation of ICU Medical’s long-term IV systems product road map that seeks to blend ease of use with proven medication delivery and safety SAN CLEMENTE, Calif. , Aug. 29, 2023 /PRNewswire/ — ICU Medical Inc., a worldwide leader…

Continue Reading